Serum EGFR and Serum HER-2/neu Are Useful Predictive and Prognostic Markers in Metastatic Breast Cancer Patients Treated With Metronomic Chemotherapy

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)176-177
Number of pages2
JournalBreast Diseases
Issue number2
StatePublished - Jul 1 2008

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this